RVL Pharmaceuticals
Kristin Comer is an accomplished legal professional, currently serving as General Counsel at RVL Pharmaceuticals since December 2023. Prior to this role, Kristin was the General Counsel and Chief Compliance Officer at RedHill Biopharma, Inc. from July 2022 to December 2023. Kristin's extensive experience includes a position as Vice President and Assistant General Counsel at Syneos Health, where leadership was provided to a global team and key advisory contributions were made on legal and corporate strategy. Previous roles at GSK involved serving as Assistant General Counsel with a focus on marketing, risk management, and governance. With a substantial legal background, Kristin held various positions at Coventry Health Care, including Managing Attorney for Dispute Resolution and Risk Management, and an earlier role as an Attorney at McDermott Will & Emery LLP. Kristin is a graduate of Northwestern University Pritzker School of Law with a JD and holds a BA in Economics and Political Science from DePauw University.
This person is not in any offices
RVL Pharmaceuticals
RVL Pharmaceuticals plc is a specialty pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. The Company is currently commercializing UPNEEQ® (oxymetazoline hydrocholoride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults. UPNEEQ is the first non-surgical treatment option approved by the FDA for acquired blepharoptosis.